Evidence map›Paper›PMID 21892206›Full record

ArticleOncogene2012

Different phenotypic consequences of simultaneous versus stepwise Apc loss.

J M Fischer, A J Miller, D Shibata, R M Liskay

Abstract read
In one paragraph

Article in Oncogene, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Single cell lineage tracing reveals a role for TgfβR2 in intestinal stem cell dynamics and differentiation.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  3. Dietary Methyl Donor Depletion Suppresses Intestinal Adenoma Development.Cancer prevention research (Philadelphia, Pa.) · 2016
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. More than two decades of Apc modeling in rodents.Biochimica et biophysica acta · 2013
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

J M FischerMolecular and Medical Genetics, Oregon Health and Science University, Portland, OR 97239, USA.
A J Miller
D Shibata
R M Liskay
Oregon Health & Science University · USUniversity of Southern California · US

Funding

INTRACHROMOSOMAL RECOMBINATION IN MAMMALIAN CELLSR01GM032741 · NIGMS · YALE UNIVERSITY · PI LISKAY, ROBERT MICHAEL · 1985 to 2013
$1.6M
Training in Developmental BiologyT32HD046420 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI GROMPE, MARKUS · 2005 to 2009
$796k
NICHD NIH HHS 5T32HD046420-05NICHD NIH HHS T32 HD046420NIGMS NIH HHS 2R01GM032741-28NIGMS NIH HHS R01 GM032741
6 · The paper itself

Abstract

APC is considered a gatekeeper for colorectal cancer (CRC). Cells with heterozygous APC mutations have altered expression profiles suggesting that the first APC hit may help set the stage for subsequent transformation. Therefore, we measured transformation efficiency following what we have designated as 'simultaneous' versus 'stepwise' Apc loss. We combined a conditional Apc allele (Apc(CKO)) with a Cre reporter gene and an out-of-frame Cre allele (Pms2(cre)) that stochastically becomes functional by a frameshift mutation in single cells. Loss of one Apc allele (Apc(CKO/+)) had little consequence, whereas simultaneous loss of both Apc alleles (Apc(CKO/CKO)) resulted in increased clonal expansion (crypt fission), consistent with the gatekeeper function of Apc. Interestingly, our analyses showed that most of the Apc-deficient crypts in Apc(CKO/CKO) mice appeared normal, with morphological transformation, including β-catenin deregulation, occurring in only 17% of such crypts. To determine whether transformation efficiency was different following stepwise Apc loss, we combined Apc(CKO) with a germline mutant allele, either Apc(Min) or Apc(1638N). Transformation efficiency following stepwise Apc loss (Apc(Min/CKO) or Apc(1638N/CKO)) was increased five-fold and essentially all of the Apc-deficient cells were dysplastic. In summary, our data suggest that the gatekeeper function of Apc consists of two roles, clonal expansion and morphological transformation, because simultaneous Apc loss frequently leads to occult clonal expansion without morphological transformation, whereas stepwise Apc loss more often results in visible neoplasia. Finally, that Apc-deficient cells in certain scenarios can retain a normal phenotype is unexpected and may have clinical implications for surveillance strategies to prevent CRC.

Indexed as

Genes, APCMutationAllelesAnimalsCell Transformation, NeoplasticColorectal NeoplasmsIntegrasesIntestine, SmallMicePhenotypeSignal TransductionCre recombinaseIntegrases

Identifiers

PMID21892206
PMCPMC3235266
OpenAlexW1976658402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.